Literature DB >> 15177764

The nature of multiple sclerosis.

Charles M Poser1, Vesna V Brinar.   

Abstract

Multiple sclerosis (MS) has recently been classified according to its clinical course. Despite relapses and remissions, its course is invariably progressive, and the observed progression from the remitting-relapsing to the secondary progressive form represents the accumulation of permanent damage to the nervous system. Discussions of the nomenclatural position of Schilder's, Marburg's, and Baló's diseases, ignore the fact that the unique, pathognomonic, sharp-edged plaque of MS, is also the pathologic end-result in the three variants. Devic's disease or neuromyelitis optica (NMO) is quite different and with some exceptions, is a particular form of disseminated encephalomyelitis (DEM). There is no evidence that the 'oriental form of MS' is anything but NMO. The suggestion that MS and DEM are variants of the same condition is contradicted by the fact that the pathological characteristics of the two are quite different. While it is probable that the two share aspects of pathogenesis, the patients differ because of their genetic endowment. This was dramatically demonstrated in a group of Japanese patients who died after anti-rabies vaccination and were found to have the typical sharp-edged lesions of MS. The genetic determinant was also crucial in the marmoset in which EAE uniquely resulted in a chronic relapsing-remitting (RR) disease characterized by the classic sharp-edged lesions of MS. The question 'ADEM: distinct disease or part of the MS spectrum?' can be answered with a resounding no. A new classification is proposed separating the different forms of MS from the various types of DEM.

Entities:  

Mesh:

Year:  2004        PMID: 15177764     DOI: 10.1016/j.clineuro.2004.02.005

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  12 in total

Review 1.  MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings.

Authors:  A Seewann; C Enzinger; M Filippi; F Barkhof; A Rovira; A Gass; D Miller; X Montalban; A Thompson; T Yousry; M Tintore; N de Stefano; J Palace; M Rovaris; C Polman; F Fazekas
Journal:  J Neurol       Date:  2007-11-15       Impact factor: 4.849

2.  Heterogeneous depression trajectories in multiple sclerosis patients.

Authors:  Douglas D Gunzler; Nathan Morris; Adam Perzynski; Daniel Ontaneda; Farren Briggs; Deborah Miller; Robert A Bermel
Journal:  Mult Scler Relat Disord       Date:  2016-08-05       Impact factor: 4.339

3.  Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.

Authors:  Nicole Trager; Amena Smith; Gerald Wallace Iv; Mitsuyoshi Azuma; Jun Inoue; Craig Beeson; Azizul Haque; Naren L Banik
Journal:  J Neurochem       Date:  2014-02-12       Impact factor: 5.372

4.  Gadolinium-Enhanced Susceptibility-Weighted Imaging in Multiple Sclerosis: Optimizing the Recognition of Active Plaques for Different MR Imaging Sequences.

Authors:  L L F do Amaral; D C Fragoso; R H Nunes; I A Littig; A J da Rocha
Journal:  AJNR Am J Neuroradiol       Date:  2019-03-07       Impact factor: 3.825

5.  Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.

Authors:  Mirja Wallner-Blazek; Alex Rovira; Massimo Fillipp; Mara A Rocca; David H Miller; Klaus Schmierer; Jette Frederiksen; Achim Gass; Hugo Gama; Charles P Tilbery; Antonio J Rocha; José Flores; Frederik Barkhof; Alexandra Seewann; Jacqueline Palace; Tarek Yousry; Xavier Montalban; Christian Enzinger; Franz Fazekas
Journal:  J Neurol       Date:  2013-04-26       Impact factor: 4.849

6.  [Spinal infections].

Authors:  I Grunwald; P Papanagiotou; M Politi; C Roth; M Backens; F Ahlhelm; W Reith
Journal:  Radiologe       Date:  2006-12       Impact factor: 0.635

Review 7.  Demyelinating diseases.

Authors:  S Love
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

Review 8.  Differential diagnosis of white matter lesions: Nonvascular causes-Part II.

Authors:  S Weidauer; M Nichtweiss; E Hattingen
Journal:  Clin Neuroradiol       Date:  2014-02-12       Impact factor: 3.649

9.  IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis.

Authors:  Youjin Lee; Meike Mitsdoerffer; Sheng Xiao; Guangxiang Gu; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Clin Invest       Date:  2015-09-28       Impact factor: 14.808

10.  The Involvement of Calpain in CD4+ T Helper Cell Bias in Multple Sclerosis.

Authors:  Nicole Trager; Jonathan T Butler; Azizul Haque; Swapan K Ray; Craig Beeson; Naren L Banik
Journal:  J Clin Cell Immunol       Date:  2013-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.